Aetiology of chronic kidney disease and risk factors for disease progression in Chinese subjects: A single‐centre retrospective study in Beijing

Aim To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression. Methods Single‐centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010‐Apri...

Full description

Saved in:
Bibliographic Details
Published inNEPHROLOGY Vol. 25; no. 9; pp. 714 - 722
Main Authors Sui, Zhun, Wang, Jiemin, Cabrera, Claudia, Wei, Jia, Wang, Mi, Zuo, Li
Format Journal Article Publication
LanguageEnglish
Published Melbourne John Wiley & Sons Australia, Ltd 01.09.2020
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1320-5358
1440-1797
1440-1797
DOI10.1111/nep.13714

Cover

Abstract Aim To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression. Methods Single‐centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010‐April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression. Results Of 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1‐2); DN and HTN were common in advanced‐stages (stages 3‐4). In a longitudinal subcohort of 2923 patients with ≥6‐month follow‐up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro‐ and micro‐albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM). Conclusion This study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression. SUMMARY AT A GLANCE This study identified diabetic nephropathy was a strong predictor of faster disease progression, and confirmed albuminuria to be associated with highest risk for disease progression.
AbstractList This study identified diabetic nephropathy was a strong predictor of faster disease progression, and confirmed albuminuria to be associated with highest risk for disease progression.
To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.AIMTo assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.Single-centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010-April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression.METHODSSingle-centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010-April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression.Of 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1-2); DN and HTN were common in advanced-stages (stages 3-4). In a longitudinal subcohort of 2923 patients with ≥6-month follow-up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro- and micro-albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM).RESULTSOf 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1-2); DN and HTN were common in advanced-stages (stages 3-4). In a longitudinal subcohort of 2923 patients with ≥6-month follow-up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro- and micro-albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM).This study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression.CONCLUSIONThis study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression.
To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression. Single-centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010-April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression. Of 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1-2); DN and HTN were common in advanced-stages (stages 3-4). In a longitudinal subcohort of 2923 patients with ≥6-month follow-up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro- and micro-albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM). This study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression.
Aim To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression. Methods Single‐centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010‐April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression. Results Of 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1‐2); DN and HTN were common in advanced‐stages (stages 3‐4). In a longitudinal subcohort of 2923 patients with ≥6‐month follow‐up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro‐ and micro‐albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM). Conclusion This study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression. SUMMARY AT A GLANCE This study identified diabetic nephropathy was a strong predictor of faster disease progression, and confirmed albuminuria to be associated with highest risk for disease progression.
AimTo assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.MethodsSingle‐centre retrospective study evaluating thorough electronic medical records of patients diagnosed with CKD at Peking University People's Hospital (April 2010‐April 2015). The objectives were to identify the aetiological factors of CKD in Chinese patients and risk factors associated with CKD progression.ResultsOf 15 425 CKD patients, 12 380 had aetiology recorded. The leading aetiologies associated with CKD were chronic glomerulonephritis (CGN; 36.8%), hypertensive nephropathy (HTN; 28.5%) and diabetic nephropathy (DN; 27.1%). CGN was most common in patients with early stage disease (stages 1‐2); DN and HTN were common in advanced‐stages (stages 3‐4). In a longitudinal subcohort of 2923 patients with ≥6‐month follow‐up, 19.6% experienced CKD progression. Patients with CKD progression were significantly older in age and had a greater number of comorbidities and laboratory anomalies, and were more likely to have DN (40.5%) and CGN (40.5%) than HTN (5.5%) at baseline than patients without progression. In a multivariate analysis, factors associated with disease progression included macro‐ and micro‐albuminuria, anaemia, hyperkalaemia, hyperphosphataemia, metabolic acidosis, CKD stage 4 and type 2 diabetes mellitus (T2DM).ConclusionThis study identified CGN, DN and HTN as the leading aetiological factors for CKD in Chinese patients. DN was a strong predictor of faster disease progression, with albuminuria (a complication of T2DM) associated with highest risk for disease progression.
Author Cabrera, Claudia
Sui, Zhun
Wang, Jiemin
Wang, Mi
Zuo, Li
Wei, Jia
AuthorAffiliation 2 AstraZeneca Global R&D Information Shanghai China
4 Department of Medical Epidemiology and Biostatistics Karolinska Institute Stockholm Sweden
1 Department of Nephrology Peking University People's Hospital Beijing China
3 AstraZeneca R&D Gothenburg Sweden
AuthorAffiliation_xml – name: 2 AstraZeneca Global R&D Information Shanghai China
– name: 4 Department of Medical Epidemiology and Biostatistics Karolinska Institute Stockholm Sweden
– name: 3 AstraZeneca R&D Gothenburg Sweden
– name: 1 Department of Nephrology Peking University People's Hospital Beijing China
Author_xml – sequence: 1
  givenname: Zhun
  surname: Sui
  fullname: Sui, Zhun
  organization: Peking University People's Hospital
– sequence: 2
  givenname: Jiemin
  surname: Wang
  fullname: Wang, Jiemin
  organization: AstraZeneca Global R&D Information
– sequence: 3
  givenname: Claudia
  surname: Cabrera
  fullname: Cabrera, Claudia
  organization: Karolinska Institute
– sequence: 4
  givenname: Jia
  surname: Wei
  fullname: Wei, Jia
  organization: AstraZeneca Global R&D Information
– sequence: 5
  givenname: Mi
  surname: Wang
  fullname: Wang, Mi
  organization: Peking University People's Hospital
– sequence: 6
  givenname: Li
  orcidid: 0000-0002-7340-5995
  surname: Zuo
  fullname: Zuo, Li
  email: zuolimd@hotmail.com
  organization: Peking University People's Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32180286$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:$$DView record from Swedish Publication Index
BookMark eNp9ks1uEzEQxy1URD_gwAsgS1zgsK2_svZyQApR-ZAq4ABna9c7Tpxs7GDvttobj4B4RJ4EpwkRrQSWLI9mfv_RzHhO0ZEPHhB6Ssk5zefCw-accknFA3RChSAFlZU8yjZnpJjwiTpGpyktCaGSlfQROuaMKsJUeYJ-TqF3oQvzEQeLzSIG7wxeudbDiFuXoE6Aa9_i6NIK29r0ISZsQzwENzHMI6TkgsfO49nCecjuNDRLMH16hac4OT_v4Nf3HwZ8HwFH6GNImxx215nsh3bcSt-AW2byMXpo6y7Bk_17hr6-vfwye19cfXr3YTa9KoxQVBQ1Kw2vLFSWlpaXypoWCGsqKURllRSmEdIq03BCy4YwKVTJmWRV1RBBWMX5GSp2edMNbIZGb6Jb13HUoXZ671plC3QphFAi8693fI6sob3tpe7uyO5GvFvoebjWUlQlIzQneLFPEMO3AVKv1y4Z6LraQxiSZlwqQhhRk4w-v4cuwxB9HodmgpN8-YRk6tnfFR1K-fO9GXi5A0yed4pgDwglers6Oq-Ovl2dzF7cY43r67wc22Zc9z_Fjetg_Hdq_fHy807xGzEQ2Ek
CitedBy_id crossref_primary_10_3389_fmed_2022_863275
crossref_primary_10_1155_2022_9613062
crossref_primary_10_1186_s12882_024_03711_x
crossref_primary_10_2147_IJNRD_S248075
crossref_primary_10_1016_j_healthpol_2024_105244
crossref_primary_10_3389_fphar_2023_1108861
crossref_primary_10_1038_s41440_024_01698_4
crossref_primary_10_1111_jch_14776
crossref_primary_10_3389_fendo_2022_859266
Cites_doi 10.1016/S0140-6736(12)60033-6
10.1681/ASN.2008080860
10.1159/000348638
10.1136/pmj.79.930.206
10.1056/NEJMoa1813599
10.1681/ASN.2017111163
10.1056/NEJMoa1901713
10.1159/000108755
10.1016/S0828-282X(07)70806-1
10.1038/sj.ijo.0803354
10.1093/ndt/gfn767
10.1371/journal.pone.0158765
10.2215/CJN.01730215
10.1053/j.ajkd.2007.11.009
10.7326/0003-4819-150-9-200905050-00006
10.1016/S0140-6736(13)60687-X
10.1093/ndt/gfn604
10.1016/j.cca.2007.09.020
10.1186/1471-2369-15-205
10.1056/NEJMc1602469
10.1111/j.1523-1755.2005.09416.x
10.1097/MD.0000000000003872
10.1038/sj.ki.5002481
10.1371/journal.pone.0047100
10.1053/j.ajkd.2014.08.023
10.1111/j.1440-1797.2011.01503.x
10.1007/s11255-012-0194-0
10.1111/j.1523-1755.2004.00837.x
10.1038/s41598-019-46857-7
10.1097/MD.0000000000003013
ContentType Journal Article
Publication
Copyright 2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology.
2020 The Authors. Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology.
2020. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2020 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology.
– notice: 2020 The Authors. Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology.
– notice: 2020. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
K9.
7X8
5PM
ADTPV
BZJLE
D8T
STUKM
DOI 10.1111/nep.13714
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
PubMed Central (Full Participant titles)
SwePub
SwePub Other
SWEPUB Freely available online
SwePub Other full text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Calcium & Calcified Tissue Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic

MEDLINE

ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Sui et al
EISSN 1440-1797
EndPage 722
ExternalDocumentID oai_swepub_ki_se_644484
PMC7496201
32180286
10_1111_nep_13714
NEP13714
Genre article
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GrantInformation_xml – fundername: AstraZeneca
– fundername: ;
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1OB
1OC
24P
29M
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
KMS
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOQ
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XVB
YFH
ZZTAW
~IA
~WT
AAYXX
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QP
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
7X8
5PM
ADTPV
BZJLE
D8T
STUKM
ID FETCH-LOGICAL-c4814-a26c39fe9f16f368fcde02b97449f874cb47f8cb3016b027486327299b0402933
IEDL.DBID DR2
ISSN 1320-5358
1440-1797
IngestDate Mon Sep 01 03:31:32 EDT 2025
Thu Aug 21 18:15:18 EDT 2025
Fri Jul 11 05:00:05 EDT 2025
Fri Jul 25 10:12:20 EDT 2025
Thu Apr 03 07:05:52 EDT 2025
Thu Apr 24 23:02:39 EDT 2025
Tue Jul 01 01:01:07 EDT 2025
Wed Jan 22 16:34:20 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords chronic kidney diseases
hypertensive nephropathy
disease progression
diabetic nephropathies
glomerulonephritis
Language English
License Attribution-NonCommercial
2020 The Authors. Nephrology published by John Wiley & Sons Australia, Ltd on behalf of Asian Pacific Society of Nephrology.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4814-a26c39fe9f16f368fcde02b97449f874cb47f8cb3016b027486327299b0402933
Notes Funding information
Zhun Sui and Jiemin Wang contributed equally to this article.
AstraZeneca
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Funding information AstraZeneca
ORCID 0000-0002-7340-5995
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnep.13714
PMID 32180286
PQID 2430243350
PQPubID 2045121
PageCount 9
ParticipantIDs swepub_primary_oai_swepub_ki_se_644484
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7496201
proquest_miscellaneous_2378002085
proquest_journals_2430243350
pubmed_primary_32180286
crossref_primary_10_1111_nep_13714
crossref_citationtrail_10_1111_nep_13714
wiley_primary_10_1111_nep_13714_NEP13714
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2020
PublicationDateYYYYMMDD 2020-09-01
PublicationDate_xml – month: 09
  year: 2020
  text: September 2020
PublicationDecade 2020
PublicationPlace Melbourne
PublicationPlace_xml – name: Melbourne
– name: Australia
– name: Richmond
PublicationTitle NEPHROLOGY
PublicationTitleAlternate Nephrology (Carlton)
PublicationYear 2020
Publisher John Wiley & Sons Australia, Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons Australia, Ltd
– name: Wiley Subscription Services, Inc
References 2002; 39
2004; 66
2018; 29
2009; 24
2019; 9
2009; 20
2003; 79
2016; 95
2009; 150
2013; 382
2007; 72
2013; 181
2007; 31
2008; 387
2008; 51
2011; 16
2019; 381
2005; 67
2016; 11
2012; 3
2015; 65
2008; 28
2014; 15
2019
2016; 375
2012; 379
2012; 7
2009; 19
2012; 44
2007; 23
e_1_2_8_28_1
e_1_2_8_29_1
National Kidney Foundation (e_1_2_8_15_1) 2002; 39
e_1_2_8_24_1
e_1_2_8_25_1
China Kidney Disease Network (CK‐NET) (e_1_2_8_27_1) 2019; 9
e_1_2_8_26_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_21_1
e_1_2_8_22_1
KDIGO (e_1_2_8_16_1) 2012; 3
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_14_1
e_1_2_8_35_1
Yao Q (e_1_2_8_23_1) 2009; 19
e_1_2_8_32_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_30_1
References_xml – volume: 11
  year: 2016
  article-title: Global prevalence of chronic kidney disease—a systematic review and meta‐analysis
  publication-title: PLoS One
– volume: 31
  start-page: 177
  year: 2007
  end-page: 188
  article-title: Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China
  publication-title: Int J Obes
– volume: 16
  start-page: 633
  year: 2011
  end-page: 641
  article-title: Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI)
  publication-title: Nephrology (Carlton)
– volume: 3
  start-page: 136
  year: 2012
  end-page: 150
  article-title: Clinical practice guideline for the evaluation and management of chronic kidney disease
  publication-title: Kidney Int Suppl
– volume: 375
  start-page: 905
  year: 2016
  end-page: 906
  article-title: Trends in chronic kidney disease in China
  publication-title: N Engl J Med
– volume: 181
  start-page: 22
  year: 2013
  end-page: 30
  article-title: Changing spectrum of biopsy‐proven primary glomerular diseases over the past 15 years: a single‐center study in China
  publication-title: Contrib Nephrol
– volume: 51
  start-page: 373
  year: 2008
  end-page: 384
  article-title: Prevalence and factors associated with CKD: a population study from Beijing
  publication-title: Am J Kidney Dis
– volume: 24
  start-page: 2117
  year: 2009
  end-page: 2123
  article-title: Community‐based study on CKD subjects and the associated risk factors
  publication-title: Nephrol Dial Transplant
– volume: 28
  start-page: 1
  year: 2008
  end-page: 7
  article-title: Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China
  publication-title: Am J Nephrol
– volume: 15
  start-page: 205
  year: 2014
  article-title: Prevalence of chronic kidney disease and associated factors among the Chinese population in Taian, China
  publication-title: BMC Nephrol
– volume: 79
  start-page: 206
  year: 2003
  end-page: 213
  article-title: Acute glomerulonephritis
  publication-title: Postgrad Med J
– volume: 7
  year: 2012
  article-title: High prevalence and associated risk factors for impaired renal function and urinary abnormalities in a rural adult population from southern China
  publication-title: PLoS One
– volume: 66
  start-page: 920
  year: 2004
  end-page: 923
  article-title: Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies
  publication-title: Kidney Int
– volume: 95
  year: 2016
  article-title: Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross‐sectional study
  publication-title: Medicine
– volume: 29
  start-page: 1411
  year: 2018
  end-page: 1425
  article-title: Mechanism of hyperkalemia‐induced metabolic acidosis
  publication-title: J Am Soc Nephrol
– volume: 39
  start-page: S1
  year: 2002
  end-page: S266
  article-title: K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification
  publication-title: Am J Kidney Dis
– volume: 9
  year: 2019
  article-title: Prevalence and risk factors of chronic kidney disease and diabetic kidney disease in Chinese rural residents: a cross‐sectional survey
  publication-title: Sci Rep
– volume: 19
  year: 2009
  article-title: Dialysis status in China: a report from the Shanghai Dialysis Registry (2000‐2005)
  publication-title: Ethn Dis
– volume: 381
  start-page: 1011
  year: 2019
  end-page: 1022
  article-title: Roxadustat treatment for anemia in patients undergoing long‐term dialysis
  publication-title: N Engl J Med
– volume: 24
  start-page: 1205
  year: 2009
  end-page: 1212
  article-title: Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China
  publication-title: Nephrol Dial Transplant
– volume: 150
  start-page: 604
  year: 2009
  end-page: 612
  article-title: A new equation to estimate glomerular filtration rate
  publication-title: Ann Intern Med
– volume: 65
  start-page: 147
  year: 2015
  end-page: 151
  article-title: Peritoneal dialysis in China: meeting the challenge of chronic kidney failure
  publication-title: Am J Kidney Dis
– volume: 72
  start-page: S4
  year: 2007
  end-page: S9
  article-title: Anemia as a risk factor for chronic kidney disease
  publication-title: Kidney Int Suppl
– volume: 382
  start-page: 260
  year: 2013
  end-page: 272
  article-title: Chronic kidney disease: global dimension and perspectives
  publication-title: Lancet
– volume: 11
  start-page: 90
  year: 2016
  end-page: 100
  article-title: Association between serum potassium and outcomes in patients with reduced kidney function
  publication-title: Clin J Am Soc Nephrol
– volume: 95
  year: 2016
  article-title: Risk factors for development and progression of chronic kidney disease: a systematic review and exploratory meta‐analysis
  publication-title: Medicine
– volume: 9
  start-page: e1
  year: 2019
  end-page: e81
  article-title: 2015 Annual Data Report
  publication-title: Kidney Int Suppl
– volume: 67
  start-page: S63
  year: 2005
  end-page: S67
  article-title: Prevention of the progression of chronic kidney disease: practice in China
  publication-title: Kidney Int Suppl
– volume: 387
  start-page: 128
  year: 2008
  end-page: 132
  article-title: Investigation of the prevalence of CKD in 13,383 Chinese hospitalised adult patients
  publication-title: Clin Chim Acta
– volume: 44
  start-page: 1269
  year: 2012
  end-page: 1276
  article-title: Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: a comparison between 1990‐1991 and 2009‐2010
  publication-title: Int Urol Nephrol
– volume: 381
  start-page: 1001
  year: 2019
  end-page: 1010
  article-title: Roxadustat for anemia in patients with kidney disease not receiving dialysis
  publication-title: N Engl J Med
– volume: 23
  start-page: 585
  year: 2007
  end-page: 590
  article-title: Improving outcomes in diabetes and chronic kidney disease: the basis for Canadian guidelines
  publication-title: Can J Cardiol
– volume: 20
  start-page: 1199
  year: 2009
  end-page: 1209
  article-title: Prediction, progression, and outcomes of chronic kidney disease in older adults
  publication-title: J Am Soc Nephrol
– year: 2019
– volume: 379
  start-page: 815
  year: 2012
  end-page: 822
  article-title: Prevalence of chronic kidney disease in China: a cross‐sectional survey
  publication-title: Lancet
– ident: e_1_2_8_3_1
  doi: 10.1016/S0140-6736(12)60033-6
– ident: e_1_2_8_12_1
  doi: 10.1681/ASN.2008080860
– ident: e_1_2_8_20_1
  doi: 10.1159/000348638
– ident: e_1_2_8_9_1
  doi: 10.1136/pmj.79.930.206
– ident: e_1_2_8_26_1
  doi: 10.1056/NEJMoa1813599
– ident: e_1_2_8_36_1
  doi: 10.1681/ASN.2017111163
– ident: e_1_2_8_25_1
  doi: 10.1056/NEJMoa1901713
– volume: 3
  start-page: 136
  year: 2012
  ident: e_1_2_8_16_1
  article-title: Clinical practice guideline for the evaluation and management of chronic kidney disease
  publication-title: Kidney Int Suppl
– ident: e_1_2_8_21_1
  doi: 10.1159/000108755
– volume: 39
  start-page: S1
  year: 2002
  ident: e_1_2_8_15_1
  article-title: K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification
  publication-title: Am J Kidney Dis
– ident: e_1_2_8_29_1
  doi: 10.1016/S0828-282X(07)70806-1
– ident: e_1_2_8_24_1
  doi: 10.1038/sj.ijo.0803354
– volume: 9
  start-page: e1
  year: 2019
  ident: e_1_2_8_27_1
  article-title: 2015 Annual Data Report
  publication-title: Kidney Int Suppl
– ident: e_1_2_8_5_1
  doi: 10.1093/ndt/gfn767
– ident: e_1_2_8_31_1
  doi: 10.1371/journal.pone.0158765
– ident: e_1_2_8_13_1
  doi: 10.2215/CJN.01730215
– ident: e_1_2_8_4_1
  doi: 10.1053/j.ajkd.2007.11.009
– ident: e_1_2_8_14_1
  doi: 10.7326/0003-4819-150-9-200905050-00006
– ident: e_1_2_8_35_1
– ident: e_1_2_8_2_1
  doi: 10.1016/S0140-6736(13)60687-X
– volume: 19
  year: 2009
  ident: e_1_2_8_23_1
  article-title: Dialysis status in China: a report from the Shanghai Dialysis Registry (2000‐2005)
  publication-title: Ethn Dis
– ident: e_1_2_8_7_1
  doi: 10.1093/ndt/gfn604
– ident: e_1_2_8_32_1
  doi: 10.1016/j.cca.2007.09.020
– ident: e_1_2_8_6_1
  doi: 10.1186/1471-2369-15-205
– ident: e_1_2_8_17_1
  doi: 10.1056/NEJMc1602469
– ident: e_1_2_8_22_1
  doi: 10.1111/j.1523-1755.2005.09416.x
– ident: e_1_2_8_18_1
  doi: 10.1097/MD.0000000000003872
– ident: e_1_2_8_34_1
  doi: 10.1038/sj.ki.5002481
– ident: e_1_2_8_8_1
  doi: 10.1371/journal.pone.0047100
– ident: e_1_2_8_10_1
  doi: 10.1053/j.ajkd.2014.08.023
– ident: e_1_2_8_30_1
  doi: 10.1111/j.1440-1797.2011.01503.x
– ident: e_1_2_8_11_1
  doi: 10.1007/s11255-012-0194-0
– ident: e_1_2_8_19_1
  doi: 10.1111/j.1523-1755.2004.00837.x
– ident: e_1_2_8_28_1
  doi: 10.1038/s41598-019-46857-7
– ident: e_1_2_8_33_1
  doi: 10.1097/MD.0000000000003013
SSID ssj0017261
Score 2.314155
Snippet Aim To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression. Methods Single‐centre retrospective...
This study identified diabetic nephropathy was a strong predictor of faster disease progression, and confirmed albuminuria to be associated with highest risk...
To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression. Single-centre retrospective study...
AimTo assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.MethodsSingle‐centre retrospective study...
To assess the aetiological factors of chronic kidney disease (CKD) and factors associated with disease progression.AIMTo assess the aetiological factors of...
SourceID swepub
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 714
SubjectTerms Acidosis
Aged
China - epidemiology
chronic kidney diseases
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - epidemiology
diabetic nephropathies
Diabetic Nephropathies - complications
Diabetic Nephropathies - diagnosis
Diabetic Nephropathies - epidemiology
Disease Progression
Electronic medical records
Etiology
Female
Glomerulonephritis
Humans
Hypertension, Renal - complications
Hypertension, Renal - epidemiology
hypertensive nephropathy
Kidney diseases
Male
Metabolic acidosis
Middle Aged
Multivariate analysis
Nephritis - complications
Nephritis - epidemiology
Nephropathy
Original
Patients
Renal Insufficiency, Chronic - diagnosis
Renal Insufficiency, Chronic - epidemiology
Renal Insufficiency, Chronic - etiology
Retrospective Studies
Risk Assessment - methods
Risk Assessment - statistics & numerical data
Risk Factors
Title Aetiology of chronic kidney disease and risk factors for disease progression in Chinese subjects: A single‐centre retrospective study in Beijing
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnep.13714
https://www.ncbi.nlm.nih.gov/pubmed/32180286
https://www.proquest.com/docview/2430243350
https://www.proquest.com/docview/2378002085
https://pubmed.ncbi.nlm.nih.gov/PMC7496201
http://kipublications.ki.se/Default.aspx?queryparsed=id
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SFEovfT_cpotaSunFy9rSynJy2m2yhEJDKA3kUDCWLJHtBm_Y9R7aU39C6U_ML8noYVM3LZTejDXCSJ4ZfSONvgF4rXMMq4zRMeU8j5k0aSy54LHEtchwYyStXILsET88Ye9Px6dbsNfehfH8EN2Gm7UM56-tgZdy_YuR1_pimFi-OfS_CeWWN3__Y0cdhesyT9obwmM6FoFVyGbxdD37a9E1gHk9TzKwifaBrFuJZnfhczsGn4CyGG4aOVTffqN3_M9B3oM7AaGSiVep-7Cl6wdw60M4g38IPye68XdcyNIQ5cl1yWJe1forCec9pKwrYrPWSajnQxAbd40uJ8zzgZB5TWwJb42v1xtpN4XWu2RC7A7Gub78_sNNiiYr3ayW7a1Q4jhxbdepnn9ByUdwMjv49O4wDpUdYsVEwuIy5YrmRucm4YZyYVSlR6nE2IblRmRMSZYZoSR6Hy5t4Cw4TTEMyCX6HAQo9DFs18taPwViMGQ0CqNO9FUITjKZVblkOsvLkVHYM4K37T8uVKA9t9U3zos2_ME5LtwcR_CqE73wXB9_EtppFaUI5r4uUkYtsyMdjyJ42TWjodrTl7LWyw3K0Ez4kqgRPPF61X2FppaIT_AIsp7GdQKWBLzfUs_PHBl4xnKOIC6CN143e13CqwU-6QKRLxN2PpzC_X2ExdHBsXt49u-iz-F2ajciXPLdDmw3q41-gWitkQO4kbLjAdycTPens4Ez0iuiEUHJ
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VIgEX_qGBAgYhxCWr3djr2IjLAq0WaFcItVIvVbR2bLHdKlvtZg9w4hEQj8iTMP5JRChIiFsUjxXZmbG_GY-_AXhqJLpV1pqUci5TpmyWKi54qnAvstxaRUufIDvh40P27mh4tAEvm7swgR-iDbg5y_DrtTNwF5D-xcorc9YbOMK5C3CRIdBwrtebjy15FO7MfNDcER7SoYi8Qi6Pp-3a3Y3OQczzmZKRT7QLZf1etHsNjptRhBSUeW9dq57-8hvB4_8O8zpcjSCVjIJW3YANU92ES_vxGP4WfB-ZOlxzIQtLdODXJfNZWZnPJB75kGlVEpe4TmJJH4LwuG30aWGBEoTMKuKqeBt8vVorFxdavSAj4oIYp-bH129-VgxZmnq5aC6GEk-L67q-MrMTlLwNh7s7B6_HaSzukGomBiydZlxTaY20A24pF1aXpp8pdG-YtCJnWrHcCq1wAeLK-c6C0ww9Aalw2UGMQu_AZrWozBYQi16j1eh44nKF-CRXeSkVM7mc9q3Gngk8b35yoSPzuSvAcVo0HhDOceHnOIEnrehZoPv4k9B2oylFtPhVkTHqyB3psJ_A47YZbdUdwEwrs1ijDM1FqIqawN2gWO1XaOa4-ARPIO-oXCvgeMC7LdXsk-cDz5nkiOMSeBaUs9MlvprjkykQ_DLh5sNr3N9HWEx2PviHe_8u-ggujw_294q9t5P39-FK5uISPhdvGzbr5do8QPBWq4feRn8C5tRDnw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxEB6VIlVcKM-ypYBBCHHZKFk7XhtOARqVV1QhKvWAtIq9tgipNlGyOcCJn4D4ifwSxo9dsRQkxM2yx1rZO2N_Y4-_AXhoJLpV1pqUci5TpmyWKi54qnAvstxaRUsfIDvhRyfs1enwdAueNm9hAj9Ee-DmLMOv187Al6X9xcgrs-wNHN_cBbjIOCIJh4jetdxRuDHzQfNEeEiHItIKuTCetmt3MzqHMM8HSkY60S6S9VvReBc-NIMIESjz3qZWPf3lN37H_xzlFbgcISoZBZ26ClumugY7b-Ml_HX4PjJ1eORCFpbowK5L5rOyMp9JvPAh06okLmydxIQ-BMFx2-iDwgIhCJlVxOXwNli93ih3KrR-QkbEHWGcmR9fv_lJMWRl6tWieRZKPCmu6_rMzD6h5A04GR--f36UxtQOqWZiwNJpxjWV1kg74JZyYXVp-plC54ZJK3KmFcut0AqXH66c5yw4zdAPkAoXHUQo9CZsV4vK3AJi0We0Gt1OXKwQneQqL6ViJpfTvtXYM4HHzT8udOQ9d-k3zorG_8E5LvwcJ_CgFV0Gso8_CR00ilJEe18XGaOO2pEO-wncb5vRUt31y7Qyiw3K0FyEnKgJ7AW9ar9CM8fEJ3gCeUfjWgHHAt5tqWYfPRt4ziRHFJfAo6CbnS6xao4lUyD0ZcLNh1e4v4-wmBwe-8L-v4veg53jF-PizcvJ69twKXOHEj4Q7wC269XG3EHkVqu73kJ_AvdhQk4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Aetiology+of+chronic+kidney+disease+and+risk+factors+for+disease+progression+in+Chinese+subjects%3A+A+single%E2%80%90centre+retrospective+study+in+Beijing&rft.jtitle=Nephrology+%28Carlton%2C+Vic.%29&rft.au=Sui%2C+Zhun&rft.au=Wang%2C+Jiemin&rft.au=Cabrera%2C+Claudia&rft.au=Wei%2C+Jia&rft.date=2020-09-01&rft.issn=1320-5358&rft.eissn=1440-1797&rft.volume=25&rft.issue=9&rft.spage=714&rft.epage=722&rft_id=info:doi/10.1111%2Fnep.13714&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_nep_13714
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1320-5358&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1320-5358&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1320-5358&client=summon